Plaque characteristic | Patients without statins or antithrombotic medication (n = 72) | Patients with statins or antithrombotic medication (n = 109) | ||
---|---|---|---|---|
OR [95% CI] | P‐value | OR [95% CI] | P‐value | |
IPH presence | 5.29 [1.54‐18.06] | 0.01* | 0.72 [0.30‐1.71] | 0.46 |
Relative IPH volume (%) | 1.19 [1.04‐1.35] | 0.01* | 1.00 [0.94‐1.06] | 0.91 |
LRNC presence | 2.45 [0.78‐7.69] | 0.13 | 0.61 [0.26‐1.47] | 0.27 |
Relative LRNC volume (%) | 1.12 [1.03‐1.21] | 0.01* | 0.98 [0.94‐1.02] | 0.36 |
Ulceration presence | 5.93 [1.38‐25.37] | 0.02* | 2.04 [0.81‐5.13] | 0.13 |
Ulceration size | 1.70 [0.97‐3.00] | 0.07 | 1.14 [0.77‐1.69] | 0.52 |
Thin or ruptured fibrous cap | 1.51 [0.55‐4.13] | 0.42 | 0.75 [0.31‐1.80] | 0.51 |
Calcification presence | 0.85 [0.18‐3.95] | 0.84 | ‐ | 0.99 |
Relative calcification volume (%) | 1.01 [0.92‐1.11] | 0.86 | 1.02 [0.95‐1.10] | 0.59 |